Patients treated for Hodgkin's disease and non-Hodgkin's
Introduction
Most patients treated with radiotherapy and chemotherapy for Hodgkin's disease and many patients with non-Hodgkin's lymphoma can expect to survive for at least 10 years after diagnosis and may be cured.' Thus psychological and social morbidity ought to be lower than in patients with cancer with a poorer prognosis' or those whose treatment entails the loss ofa crucial part or function of the body. 24 We conducted a retrospective study to determine if this was so.
Patients and methods
We studied 98 patients with Hodgkin's disease or non-Hodgkin's lymphoma who had consecutively attended a medical oncology clinic at the Christie Hospital during a period of six months for treatment and follow up. Patients were interviewed at home by a trained interviewer (JD or HC) using a semistructured approach. Each interview was recorded on audiotape to permit rating of data and checks of reliability. The toxicity of treatment and social and psychiatric morbidity were assessed.
Treatment toxicit-Patients were questioned in depth about their treatments and any side effects they had experienced. Scales were developed to rate 13 key side effects-for example, for vomiting O=no vomiting experienced; 1=mild vomiting (one to five episodes a day for one or two days); 2=moderate (six to 10 episodes a day for one or two days or one to five episodes a day for three or more days); 3=severe (more than 10 episodes a day or six to 10 episodes a day for at least three days). A total adverse effect score for each patient was calculated by summing these 13 separate scores (maximum score=38).
Social morbidit-A shortened version of the standardised social interview schedule was used to assess patients' occupational or housework role, leisure activities, social contacts, domestic interactions, marriage, and family life.I Ratings were made for three time periods: before diagnosis, between diagnosis and the month before interview, and the month before interview. Psychiatric morbidity-An abbreviated version of the present state examination was used to assess if symptoms of anxiety and depression had occurred within the month before interview.6 Then the patient was requestioned about each symptom to determine whether it had been present between diagnosis and the month before interview and, ifso, its severity and duration. A depressive illness was diagnosed if depressed mood was present and accompanied by four or more of the following symptoms: hopelessness, social withdrawal, self depreciation, lack of self confidence, loss of appetite, early waking or delayed sleep, anergia, loss of libido, and irritability. Borderline depression was diagnosed if depressed mood was accompanied by fewer than four of these symptoms. An anxiety state was diagnosed if nervous tension was present and accompanied by four or more of the following symptoms: muscular tension, irritability, restlessness or fidgeting, tiredness, lack of concentration, early waking or delayed sleep, anxiety, loss of interest, inefficient thinking, tension pains, neglect due to brooding, and anxious foreboding. Nervous tension accompanied by fewer than four other symptoms of anxiety was rated as borderline. All data from the present state examination were rated by one interviewer (JD), and 10 audiotapes were randomly selected for independent rating by a second trained rater. Kappa coefficients were calculated for each item.7 The mean value of kappa was 0-81 (SD=0-19), indicating high reliability.8
Results
Ofthe 98 patients recruited, one died; five were not able to be interviewed, and two patients were excluded because the tape recorder failed. The final sample therefore comprised 90 patients, and none refused. The sample was representative ofall patients entered into clinical trials for treatment ofthese diseases over the previous five years. There were 47 men and 43 women (mean age 44-4 (SD 17-6) years, range 17-73 years). The mean time from diagnosis to interview was 2-7 years (range 6 months to 6 years, median 2-2 years).
Treatment toxicit- Table I shows the severity of each side effect experienced by the patients, who were treated with radiotherapy or chemotherapy, or both. Symptoms persisting at follow up were a lack of energy (31 patients), loss of libido (19 of the 77 patients who had had an active sex life before their illness), irritability (22 patients), and tiredness (19 patients). Thirty patients also complained that their thinking or short term memory was impaired.
Psychiatric morbidity- Table II shows the results obtained with the present state examination. Over the whole assessment period 21 patients suffered from an anxiety state or depressive illness, or both, and a further 27 experienced borderline anxiety or depression, or both. Depression and *Patients with combined depressive illness and anxiety state are included twice-that is, under depression and under anxiety; the same applies for patients with both borderline illnesses. fEight patients had both depressive illness and anxiety state and five both borderline depression and anxiety; two patients had depressive illness with borderline anxiety. tOne patient had both depressive illness and anxiety state and one both borderline depression and anxiety.
anxiety -correlated positively with total toxicity scores (for depression Kendall's t =0-324, p<000l; for anxiety Kendall's T=0-204, p<001) and with adverse effects affecting the gastrointestinal tract, particularly nausea, vomiting, diarrhoea, loss of appetite, and sore mouth. Social morbidity-The extent to which patients participated in their usual leisure activities declined substantially from the period before they became ill to follow up, and patients expressed considerable dissatisfaction about this (table III) . Eight of the 66 patients in regular employment before they became ill stayed off work for longer than a year despite a good physical recovery, and 17 patients gave up their jobs. 
Discussion
Our study was retrospective and possibly subject to errors of recall. The low incidence of conditioned response compared with the findings of Morrow et aP suggests that patients may have forgotten these effects with time. Thus our findings are probably an underestimate of the true impact of treatment for Hodgkin's disease and non-Hodgkin's lymphoma; even so, adverse effects of treatment were common and similar to those reported previously."' Psychiatric morbidity was three to five times higher than that found in subjects in the community."'2 Although social morbidity was low, we were concerned that a substantial proportion ofpatients delayed returning to work or failed to do so even though they were free of disease, had stopped receiving treatment, and were free of anxiety or depression. We were also concernediabout the substantial proportion who had persistent symptoms and-complained of memory impairment. We therefore conducted a prospective study to determine the exact nature, timing, and duration of,these adverse psychological and social sequelae.
